Cargando…
Prognostic value of some tumor markers in unresectable stage IV oropharyngeal carcinoma patients treated with concomitant radiochemotherapy
BACKGROUND: The aim of the study was to investigate how the expression of tumor markers p21, p27, p53, cyclin D1, EGFR, Ki-67, and CD31 influenced the outcome of advanced inoperable oropharyngeal carcinoma patients, treated with concomitant radiochemotherapy. PATIENTS AND METHODS. The pretreatment b...
Autores principales: | Soba, Erika, Budihna, Marjan, Smid, Lojze, Gale, Nina, Lesnicar, Hotimir, Zakotnik, Branko, Strojan, Primoz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Versita, Warsaw
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722927/ https://www.ncbi.nlm.nih.gov/pubmed/26834523 http://dx.doi.org/10.2478/raon-2014-0048 |
Ejemplares similares
-
Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m(2) for definitive radiochemotherapy of locally advanced head-and-neck cancers
por: Rades, Dirk, et al.
Publicado: (2016) -
Prognostic Role of Diffusion Weighted and Dynamic Contrast-enhanced MRI in Loco-regionally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiotherapy
por: Garbajs, Manca, et al.
Publicado: (2019) -
Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin
por: Kornek, G V, et al.
Publicado: (2000) -
Evaluation of Efficacy and Tolerance of Radical Radiotherapy and
Radiochemotherapy in Treatment of Locally Advanced, Unresectable Rectal
Cancer
por: Kraszkiewicz, M., et al.
Publicado: (2022) -
Radiochemotherapy
Publicado: (1998)